Overview
- 36 inspections across 36 sites are on record.
- 128 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2013-09-25.
At a glance
Inspections
36
Sites
36
Observations
128
Career since
Jul 2010
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| PCI Pharma Services Canada, Inc. | 25 Sep 2013 | Human Drugs | |
| Pancap Pharma Inc. | 19 Sep 2013 | Human Drugs | View 483 → |
| Purdue Pharma | 13 Sep 2013 | Human Drugs | View 483 → |
| Cubist Pharmaceuticals, Inc. | 20 Aug 2013 | Human Drugs | View 483 → |
| Airgas USA, LLC | 22 May 2013 | Human Drugs | View 483 → |
Sites inspected
PCI Pharma Services Canada, Inc.Mississauga, Canada1 insp.
Pancap Pharma Inc.Markham, Canada1 insp.
Purdue PharmaPickering, Canada1 insp.
Cubist Pharmaceuticals, Inc.Lexington, United States1 insp.
Airgas USA, LLCBillerica, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Ramon E Martinez5 shared
Thomas W Nerney4 shared
Rory Geyer4 shared
Stacey S Degarmo3 shared
Debra M Emerson3 shared
Amy C Jordan3 shared
Kathleen E Mcafoose3 shared
Megan A Haggerty2 shared
Almaris N Alonso2 shared
Maya M Davis1 shared
Full investigator report
Get the verbatim findings behind Philip Kreiter's 128 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site